Newsmeme!
Discover News you didn't know existed
NEW YORK----Reportlinker.com announces that a new market research report related to the Care services industry is available in its catalogue.
In October 2007, after transplanting five organs in Jeffery Ross' body, doctors said he had a good chance of living a long life. Unfortunately, they might have spoken too soon.
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure(1).
Multiple lymphomatous polyposis (MLP) is an unusual form mantle cell lymphoma characterized by polyps throughout the gastrointestinal tract. Adult T-cell leukemia/lymphoma (ATLL) is a malignancy associated with retrovirus, human T-cell lymphotropic virus type 1 (HTLV-1). Although it is well-known that ATLL cells infiltrate into systemic organs including gastrointestinal (GI) tract, colonic ...
Doctors will take a closer look at the transplanted small bowel La Vergne teen Brandon Brewer recently received, a family friend reported.
A research team from Japan presented a case of a 66-year-old man with adult T-cell leukemia/lymphoma (ATLL). They reviewed the manifestations of colonic involvement of ATLL and discussed the importance of endoscopic evaluation to differentiate ATLL intestinal lesions from opportunistic infectious enterocolitis.
Todd Sanders, here with his wife, Paula, will now be able to receive disability and benefits after the federal government recently deemed Gulf War Syndrome real. Photo by Erica Yoon.
"You can live with cancer and be happy" the founder of the Chickenshed theatre company tells Victoria Lambert
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and ...
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure (1) . The new findings demonstrated that miR-21 ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |